DLI Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

Peking University People's Hospital1

Indications

MRD-positive1
Allogenetic Hematopoietic Stem Cell Transplantation1
B-ALL1
Cancer1

Other1 trial

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.